Affiliations
AffiliationsItem in Clipboard
Recall and Cancer Detection Rates for Screening Mammography: Finding the Sweet SpotPaula Grabler et al. AJR Am J Roentgenol. 2017 Jan.
. 2017 Jan;208(1):208-213. doi: 10.2214/AJR.15.15987. Epub 2016 Sep 28. AffiliationsItem in Clipboard
AbstractObjective: The purpose of this study is to identify the optimal screening mammography recall rate range on the basis of cancer detection rates among breast imaging specialists at an academic institution.
Materials and methods: Medical outcome audit data collected in accordance with the Mammography Quality Standards Act from September 1, 2007, through August 31, 2012, were reviewed. Cancer detection rates were calculated from 984 screen-detected cancers identified in 188,959 total digital screening mammograms. The percentages of minimally invasive and early-stage cancers were also calculated. The 75 annual recall rates were analyzed two ways. First, they were separated into recall groups to assess cancer detection rate variation by the recall categories using rate ratios: less than 10%, 10% to less than 12%, 12% to less than 14%, and 14% or higher. Next, a linear regression with bootstrap bias correction was performed to assess changes in cancer detection rate with each unit increase in the recall rate up to 20%, with the recall category of less than 7% taken as reference. Annual cancer detection rates for a physician were grouped according to annual percentage recall rate.
Results: Statistically significantly higher cancer detection rates were seen for recall rates 12% or higher, with rate ratios of 1.75 (95% CI, 1.40-2.19) and 2.06 (95% CI, 1.72-2.46) for the recall groups 12% to less than 14% and 14% and higher, respectively, compared with the less than 10% group. When taking the category 12% to less than 14% as the reference, there were no statistically significant differences between recall groups 12% to less than 14% and 14% or higher in cancer detection rate. A statistically significant increase in the cancer detection rate with each unit increase in the recall rate was seen only for recall rates 12% or higher.
Conclusion: These observations suggest that the sweet spot for optimal cancer detection is in the recall rate range 12% to less than 14% with the incremental benefit above this to be relatively small. A recall rate less than 10% may be too low.
Keywords: American College of Radiology guidelines; cancer detection rates; recall rate; sweet spot.
Similar articlesOtten JD, Karssemeijer N, Hendriks JH, Groenewoud JH, Fracheboud J, Verbeek AL, de Koning HJ, Holland R. Otten JD, et al. J Natl Cancer Inst. 2005 May 18;97(10):748-54. doi: 10.1093/jnci/dji131. J Natl Cancer Inst. 2005. PMID: 15900044
Schell MJ, Yankaskas BC, Ballard-Barbash R, Qaqish BF, Barlow WE, Rosenberg RD, Smith-Bindman R. Schell MJ, et al. Radiology. 2007 Jun;243(3):681-9. doi: 10.1148/radiol.2433060372. Radiology. 2007. PMID: 17517927
Sala M, Comas M, Macià F, Martinez J, Casamitjana M, Castells X. Sala M, et al. Radiology. 2009 Jul;252(1):31-9. doi: 10.1148/radiol.2521080696. Epub 2009 May 6. Radiology. 2009. PMID: 19420316
Harvey SC, Di Carlo PA, Lee B, Obadina E, Sippo D, Mullen L. Harvey SC, et al. J Am Coll Radiol. 2016 Nov;13(11S):R74-R80. doi: 10.1016/j.jacr.2016.09.031. J Am Coll Radiol. 2016. PMID: 27814819 Review.
Lee CS, Moy L, Friedewald SM, Sickles EA, Monticciolo DL. Lee CS, et al. AJR Am J Roentgenol. 2018 Feb;210(2):241-245. doi: 10.2214/AJR.17.18704. Epub 2017 Oct 18. AJR Am J Roentgenol. 2018. PMID: 29045178 Review.
Zhou J, Xiang J, Huang S. Zhou J, et al. Sensors (Basel). 2020 Sep 9;20(18):5132. doi: 10.3390/s20185132. Sensors (Basel). 2020. PMID: 32916835 Free PMC article.
Gutierrez C, Owens A, Medeiros L, Dabydeen D, Sritharan N, Phatak P, Kandlikar SG. Gutierrez C, et al. Sci Rep. 2024 Feb 9;14(1):3316. doi: 10.1038/s41598-024-53856-w. Sci Rep. 2024. PMID: 38332177 Free PMC article.
Théberge I, Vandal N, Perron L, Guertin MH. Théberge I, et al. Breast Cancer Res Treat. 2021 May;187(1):255-266. doi: 10.1007/s10549-020-06057-8. Epub 2021 Jan 4. Breast Cancer Res Treat. 2021. PMID: 33392846
Akwo J, Hadadi I, Ekpo E. Akwo J, et al. Cancers (Basel). 2024 Oct 17;16(20):3505. doi: 10.3390/cancers16203505. Cancers (Basel). 2024. PMID: 39456600 Free PMC article. Review.
Martins RS, Arif A, Yameen S, Noordin S, Masroor T, Muhammad S, Channa M, Soofi SB, Sattar AK. Martins RS, et al. BMC Health Serv Res. 2024 May 10;24(1):616. doi: 10.1186/s12913-024-11051-7. BMC Health Serv Res. 2024. PMID: 38730486 Free PMC article.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3